A new study reveals disappointing results on the potential of GLP-1 drugs like Ozempic to treat Parkinson's disease. Despite ...

Americans will soon have access to an infusion device that provides round-the-clock effective relief of Parkinson's disease.

Treatment with exenatide, a GLP-1 receptor agonist, was comparable to placebo in slowing the rate of Parkinson’s disease ...

The legendary rocker is reuniting with original Sabbath guitarist Tony Iommi for the show at Premier League football club Aston Villla's stadium in their home city of Birmingham on July 5.

WEDNESDAY, Feb. 5, 2025 (HealthDay News) -- Hopes that GLP-1 drugs such as Ozempic and Wegovy could help slow Parkinson's ...

The GLP-1 drug, exenatide, has no positive impact on the movement, symptoms or brain imaging of people with Parkinson's ...

A final-stage study has found that exenatide, a GLP-1 drug used to treat Type 2 diabetes, showed no benefit in slowing the progression of Parkinson's disease. The 96-week trial, published in The ...

What you need to know about the new rulesPatients with Parkinson's disease get zero benefit from taking a skinny jab despite promising early results, a trial has found.Not only did they not lose ...

The lesser-known health complaint, which typically happens more at night, might leave you feeling pretty itchy, which can be unpleasant and can lead to infections if you keep picking or scratching at ...

By treating someone before noticeable symptoms start to happen, these medications could give people with early-stage Alzheimer’s more time to live an independent life. However, before a new ...

Wet dandruff—or dandruff associated with an oily scalp—happens when extra sebum (oil) production on the scalp combines with ...